Clinical trial
Study Evaluating Patients With Cystinuria
NCT04137978 · Advicenne Pharma, Industry · Withdrawn
Key facts
| NCT number | NCT04137978 |
|---|---|
| Title | Study Evaluating Patients With Cystinuria |
| Official title | Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria |
| Lead sponsor | Advicenne Pharma, Industry |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Cystinuria |
| Intervention type | Drug |
| Interventions | ADV7103, Standard of Care |
| Enrollment | 0 |
| Start date | May 1, 2024 |
| Primary completion | Jun 1, 2025 |
| Completion | Aug 1, 2025 |
| First posted | Oct 24, 2019 |
| Last update posted | Mar 12, 2024 |
| Countries | Belgium, France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: